Search
Search
Close this search box.

How to understand the gap between supply and demand in the Canadian cannabis market

The CCSI was assessed at C$5.86 per gram this week, up 0.3% from last week’s C$5.84 per gram. This week’s price equates to US$2,132 per pound at the current exchange rate.

Each week, Business of Cannabis delivers a series of insights from our partners at Cannabis Benchmarks®.

This week, Cannabis Benchmarks provides an update on the still-growing gap between supply and demand in Canada’s legal cannabis market.

Cannabis Benchmarks estimates that the total implied demand for legal cannabis in December 2020 was 30,318 kg. Despite increasing 212% year-over-year, December’s demand figure is less than 18% of the 165,189 kg of unpackaged production reported by Statistics Canada for November 2020. Total packaged and unpackaged inventory amounted to 1,165,725 kg as of November 2020, according to Statistics Canada, representing 38 months of supply at current demand levels. While some of this inventory will be drawn down by domestic demand and via exports to other countries, some product may degrade to a point where it is not sellable.

Seasonal supply from outdoor harvests, which typically take place in October and November, is amplifying the growing supply-demand imbalance.

Statistics Canada’s data shows a noticeable increase in the amount of inventory generated in those months in 2019, with the supply surge more pronounced in October and November 2020 as the country’s outdoor production capacity expanded last year.

Source: Canada Cannabis Spot IndexCannabis Benchmarks



⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?